Tag: weight loss drugs

Altcoins

India’s Affordable Weight Loss Drugs Revolution

India's semaglutide patent expired, unleashing a wave of cheap generics at 80% less. Novo is betting on brand power, but...

23/03/2026

3 views

Read More

Market News

FDA Approves Higher Dose Wegovy for Enhanced Weight Loss

The FDA just approved a stronger version of Wegovy, pushing average weight loss to over 20% in trials. Could this...

21/03/2026

3 views

Read More

Altcoins

Zealand Pharma Stock Plunges 35% on Trial Setback

When a promising obesity drug candidate delivered solid but unspectacular weight loss results, one biotech firm's shares cratered 35% overnight....

06/03/2026

2 views

Read More

Altcoins

Premarket Movers: Arcellx Soars on Acquisition Deal

One biotech stock just exploded 78% before the bell thanks to a massive buyout, while a weight-loss giant took a...

23/02/2026

1 views

Read More

Altcoins

Novo Nordisk Stock Drops After Weight Loss Drug Trial Miss

Novo Nordisk's stock took a sharp hit after its promising next-gen weight loss drug CagriSema fell short against Eli Lilly's...

23/02/2026

3 views

Read More

Market News

Novo Nordisk Stock Surges After Copycat Pill Pulled

When a telehealth company launched a $49 knockoff of the blockbuster Wegovy pill, stocks tumbled. Then came the FDA threats...

09/02/2026

3 views

Read More

Altcoins

Food Giants Adapt to Health Shifts and Challenges

Big food and drink brands once seemed unbreakable, but weight-loss meds and viral new competitors are forcing a major rethink....

08/02/2026

3 views

Read More

Market News

Pfizer’s Bold Move in Obesity Treatment Landscape

Pfizer just dropped intriguing phase 2 data on a monthly obesity shot that delivered up to 12.3% weight loss—could this...

06/02/2026

3 views

Read More

Stocks

Eli Lilly Surges Ahead in GLP-1 Market as Novo Faces 2026 Decline

While both giants face U.S. pricing squeezes on weight-loss drugs, Eli Lilly just forecasted massive 2026 growth while Novo Nordisk...

04/02/2026

5 views

Read More

Market News

Eli Lilly Crushes Q4 2025 Earnings With Massive Zepbound Boost

Eli Lilly just dropped their Q4 2025 earnings, and the numbers are staggering – revenue way above expectations thanks to...

04/02/2026

4 views

Read More